Stories about research and scientific development at Mount Sinai
Neurology Research Residency Program
Sam Horng, MD, PhD, and PGY3 resident in the Department of Neurology has been approved for funding under the Mount Sinai R25 Research Residency Program. The Program provides mentoring and dedicated time set aside for research during residency and fellowship years. Dr....
Blazing a New Trail in the Treatment of Heart Disease
An injectable nanoparticle that delivers HMG-CoA reductase inhibitors, or statins, which directly inhibit atherosclerotic plaque inflammation could represent a new frontier in the treatment of heart disease. This novel approach is being developed by researchers at...
Studying a Novel Device for Heart Failure
The Mount Sinai Hospital is one of three institutions in New York State, and one of one hundred in the nation, selected to study the safety and effectiveness of an implantable cranial nerve stimulation device for heart failure patients with debilitating fatigue,...
Advances in Tourette Syndrome Research: Histamine and Genomics
A recent NBC News article highlighted the importance of genetic research and the potential therapeutic application of histamine for individuals with Tourette Syndrome (TS). TS is a chronic neuropsychiatric disorder characterized by multiple motor and vocal tics. Onset...
New Clues to Age-Related Cognitive Decline
Mounting evidence suggests that age-related cognitive decline is caused not by nerve cell death, as it is in Alzheimer’s disease, but from a disruption in synapses, the structures that allow a nerve cell to transmit a signal to other nerve cells. Demonstrating these...
Discovering New Treatments for Lung and Airway Diseases
The creation of a trachea engineered from stem cells that can be transplanted in people with lung or airway diseases is being pioneered by physicians at St. Luke’s and Roosevelt Hospitals. The promising technology will be presented at the Society of Thoracic Surgeons...
Studying a New Treatment for Type 2 Diabetes
There are more than 23 million people in the United States, including 1.6 million in New York State, who have type 2 diabetes, which occurs when the body is resistant to the action of insulin, a hormone produced by the pancreas to lower the blood sugar. Type 2...
SinaInnovations Conference Focuses on “Team Science”
The topic of “team science” took center stage at Icahn School of Medicine at Mount Sinai’s second annual SinaInnovations conference on Monday, November 18, and Tuesday, November 19. Hundreds of scientists, students, and participants from diverse industries gathered in...
Mindfulness Meditation for Spine Surgery Pain
A joint research project between the Department of Neurosurgery and the Department of Geriatrics and Palliative Medicine is evaluating the use of meditation to decrease pain after spine surgery. This particular meditation technique has been shown in clinical trials to...